X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (23) 23
index medicus (21) 21
colorectal cancer (15) 15
humans (15) 15
aged (10) 10
cancer (10) 10
colorectal neoplasms - drug therapy (10) 10
female (10) 10
male (10) 10
middle aged (10) 10
prognosis (10) 10
colorectal neoplasms - pathology (9) 9
open-label (8) 8
chemotherapy (7) 7
colorectal neoplasms - genetics (7) 7
patients (7) 7
1st-line treatment (6) 6
bevacizumab (6) 6
biomarkers (6) 6
clinical trials (6) 6
immunotherapy (6) 6
metastasis (6) 6
metastatic colorectal cancer (6) 6
mutation (6) 6
adult (5) 5
care and treatment (5) 5
cohort studies (5) 5
expression (5) 5
survival (5) 5
therapy (5) 5
tumors (5) 5
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
biomarker (4) 4
biomarkers, tumor - genetics (4) 4
colorectal carcinoma (4) 4
disease-free survival (4) 4
double-blind (4) 4
gastric cancer (4) 4
kinases (4) 4
medical colleges (4) 4
medical research (4) 4
metastases (4) 4
neoplasm metastasis (4) 4
panitumumab (4) 4
randomized phase-iii (4) 4
ras (4) 4
research (4) 4
resistance (4) 4
stomach neoplasms - pathology (4) 4
treatment outcome (4) 4
trial (4) 4
2nd-line treatment (3) 3
adenocarcinoma (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
article (3) 3
braf (3) 3
cancer patients (3) 3
cancer therapies (3) 3
cetuximab (3) 3
colon-cancer (3) 3
deoxyribonucleic acid--dna (3) 3
drug therapy (3) 3
fluorouracil (3) 3
gastrointestinal cancer (3) 3
genetic aspects (3) 3
health aspects (3) 3
kaplan-meier estimate (3) 3
management (3) 3
medical prognosis (3) 3
medicine & public health (3) 3
metaanalysis (3) 3
microsatellite instability (3) 3
progression-free survival (3) 3
proto-oncogene proteins b-raf - genetics (3) 3
single-nucleotide polymorphism (3) 3
stomach cancer (3) 3
stomach neoplasms - drug therapy (3) 3
usage (3) 3
1st-line therapy (2) 2
advanced gastric cancer (2) 2
angiogenesis (2) 2
angiogenesis inhibitors - pharmacology (2) 2
anti-egfr monoclonal antibodies (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
biomarkers, tumor - metabolism (2) 2
brain neoplasms - diagnosis (2) 2
camptothecin - administration & dosage (2) 2
carcinoma (2) 2
cetuximab - administration & dosage (2) 2
clinical medicine (2) 2
clinical trials as topic (2) 2
colorectal neoplasms - diagnosis (2) 2
confidence intervals (2) 2
diagnosis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 08/2019, Volume 111, Issue 8, pp. 754 - 756
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, p. e0193640
Journal Article
The Oncologist, ISSN 1083-7159, 08/2016, Volume 21, Issue 8, pp. 988 - 994
Journal Article
Current Treatment Options in Oncology, ISSN 1527-2729, 12/2018, Volume 19, Issue 12, pp. 1 - 14
Journal Article
Gastric Cancer, ISSN 1436-3291, 9/2017, Volume 20, Issue 5, pp. 825 - 833
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 12/2019, Volume 81, p. 101912
Regorafenib is a multi-targeting kinase inhibitor approved for the treatment of metastatic colorectal cancer patients in refractory to standard chemotherapy.... 
Regorafenib | Biomarker | Anti-angiogenesis | Tumor microenvironment | Immunotherapy | Colorectal cancer
Journal Article
Journal Article